JP2003024010A - Function-enhancing supplementary food comprising as main ingredient green tea catechin - Google Patents
Function-enhancing supplementary food comprising as main ingredient green tea catechinInfo
- Publication number
- JP2003024010A JP2003024010A JP2001245770A JP2001245770A JP2003024010A JP 2003024010 A JP2003024010 A JP 2003024010A JP 2001245770 A JP2001245770 A JP 2001245770A JP 2001245770 A JP2001245770 A JP 2001245770A JP 2003024010 A JP2003024010 A JP 2003024010A
- Authority
- JP
- Japan
- Prior art keywords
- function
- green tea
- vitamin
- tea catechin
- enhancing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、茶の葉から抽出さ
れた緑茶カテキンを主成分とし、少量の補助薬効成分を
配合して賦形剤を加えて錠剤に造形した機能強化補助食
品に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a function-enhancing supplementary food containing green tea catechin extracted from tea leaves as a main component, a small amount of an auxiliary medicinal component, a excipient and excipients.
【0002】[0002]
【従来の技術】人間が生きていく上で酸素が必要であ
り、人間は生命維持のため有効に酸素を利用し、かつ、
体内で変化した有害成分である活性酸素に対する防御機
能を備えることによって進化してきたといわれている。
日常、人間が呼吸している酸素が、人体内で栄養成分と
反応してエネルギーを発生する際に活性化した酸素の発
生は通常の数千倍といわれている。2. Description of the Related Art Oxygen is necessary for humans to survive, and humans use oxygen effectively to maintain life, and
It is said to have evolved by having a defense function against active oxygen, which is a harmful component that has changed in the body.
It is said that the oxygen that is breathed by humans every day is activated several thousand times more than usual when oxygen reacts with nutrient components in the human body to generate energy.
【0003】[0003]
【発明が解決しようとする課題】人体は通常前記のよう
な活性酸素を除去する能力を持っているが、過労、スト
レス、偏食等種々の原因が重なってくると前記能力が著
しく低下し、自分自身では活性酸素を消去することが出
来ないことがある。The human body normally has the ability to remove active oxygen as described above. However, when various causes such as overwork, stress, and unbalanced diets are overlapped, the ability remarkably deteriorates. It may not be possible to eliminate active oxygen by itself.
【0004】その結果、活性酸素により細胞を破壊され
て「酸化障害」が発現し、老化や成人病の原因となるな
ど大きな問題となっている。この「酸素毒」とも言われ
る問題の適切な解決手段は知られていなかった。本発明
は、前記従来における問題点を解決し、必要とする抗酸
化成分と、適宜な薬効を持つ機能強化補助食品を提供す
ることを目的としている。As a result, cells are destroyed by active oxygen and "oxidative damage" is developed, which causes aging and adult diseases, which is a serious problem. No suitable solution for this problem called "oxygen poisoning" was known. It is an object of the present invention to solve the above-mentioned conventional problems and provide a necessary antioxidant component and a function-enhancing supplement food having an appropriate medicinal effect.
【0005】[0005]
【課題を解決するための手段】上記目的を達成するた
め、本発明者は鋭意研究を重ねた結果、茶の葉抽出物で
ある緑茶カテキンが必要とする活性酸素除去能力を備
え、人体の老化防止にも優れていることを知見し、本発
明を完成するに至った。[Means for Solving the Problems] In order to achieve the above object, the present inventor has conducted extensive studies, and as a result, has the ability to remove active oxygen required for green tea catechin, which is a tea leaf extract, and aged the human body. They have found that they are also excellent in prevention, and have completed the present invention.
【0006】前記の知見に基づいてなされた本発明は、
緑茶カテキンを主成分とし、副成分として、少量のガル
シニア葉粉末、ブドウ種子粉末、ビタミンB12、ビタ
ミンE、納豆菌培養エキスおよび賦形剤よりなることを
特徴とする機能強化補助食品を要旨としている。The present invention made based on the above findings is
A functional-enhancing supplement, which is mainly composed of green tea catechin and a small amount of garcinia leaf powder, grape seed powder, vitamin B 12 , vitamin E, Bacillus natto culture extract and excipients as accessory components. There is.
【0007】また本発明は、緑茶カテキンが75%以上
のポリフェノールを含む茶の葉抽出物であるもの、賦形
剤が赤玉デキストリン、乳糖およびシュガーエステルで
ある前記の機能強化補助食品もその要旨である。Further, the gist of the present invention is that the green tea catechin is a tea leaf extract containing 75% or more of polyphenols, and the above-mentioned function-enhancing supplement foods whose excipients are red ball dextrin, lactose and sugar ester. is there.
【0008】[0008]
【発明の実施の形態】本発明の構成と作用を説明する。
本発明の機能強化補助食品の主体は、茶の葉抽出物であ
り、ポリフェノール含有量が75%以上の緑茶カテキン
である。この緑茶カテキンは、強力な抗酸化酵素(SO
D)様活性を有しており、他の食品から本発明品と同等
又はそれ以上のSOD様物質を摂取することは困難であ
る。BEST MODE FOR CARRYING OUT THE INVENTION The structure and operation of the present invention will be described.
The main constituent of the functional supplement of the present invention is tea leaf extract, which is green tea catechin having a polyphenol content of 75% or more. This green tea catechin is a powerful antioxidant enzyme (SO
It has D) -like activity, and it is difficult to ingest an SOD-like substance equivalent to or better than the product of the present invention from other foods.
【0009】このような緑茶ポリフェノール(カテキン
類)の作用は、口腔内衛生、腸内環境改善、生体内抗酸
化などが知られており(「F00D Style 2
1」2000.1[Vol.4 No.1] P45〜
51、「ILSI」No.65 [2000,12]
P14〜22、株式会社シーエムシー[1996年5月
31日発行]「新食品機能素材の開発」P210〜22
3、ならびにJ.Agric.Food Chem.
1999,Vol.47,No.10 P3967〜3
973参照)、食品添加物として、例えばサンフェノン
DCF−1(商品名:太陽化学株式会社製)などが市販
されている。The effects of such green tea polyphenols (catechins) are known to be oral hygiene, improvement of intestinal environment, and in vivo antioxidant (“F00D Style 2”).
1 ”2000.1 [Vol. 4 No. 1] P45 ~
51, "ILSI" No. 65 [2000, 12]
P14-22, CMC [Published May 31, 1996] "Development of new food functional ingredients" P210-22
3, and J. Agric. Food Chem.
1999, Vol. 47, No. 10 P3967-3
As a food additive, for example, Sanphenon DCF-1 (trade name: manufactured by Taiyo Kagaku Co., Ltd.) and the like are commercially available.
【0010】配合割合は、補助食品中20.00〜3
0.00%(重量%、以下同じ)であり、20.00%
未満では緑茶カテキンの強力な抗酸化酵素(SOD)様
活性を十分に発揮できない。また30.00%を超える
と他の成分との調和が崩れるので好ましくない。より好
ましくは23.00〜27.00%の配合がよく、2
5.00%前後がもっとも効果的である。The mixing ratio is 20.00 to 3 in the supplement.
0.00% (% by weight, the same applies hereinafter), 20.00%
If it is less than the above, the strong antioxidant enzyme (SOD) -like activity of green tea catechin cannot be sufficiently exhibited. Further, if it exceeds 30.00%, the harmony with other components is lost, which is not preferable. More preferably, the proportion of 23.00 to 27.00% is good, and 2
Around 5.00% is the most effective.
【0011】本発明機能強化補助食品に添加されるガル
シニア葉粉末は、熱帯地方に生育する4種類のガルシニ
ア属樹木の葉の部分からつくられ、この中には人体内に
おけるブドウ糖から脂肪への合成を抑制する天然の
(−)HCA(ヒドロキシクエン酸)が含まれている
(前出「新食品機能素材の開発」P331〜336参
照)。上記ガルシニア葉粉末は、たとえばガルシニアリ
ーフM(商品名:清光薬品工業株式会社製)が市販され
ている。Garcinia leaf powder added to the function-enhancing supplement of the present invention is made from leaves of four kinds of Garcinia genus trees that grow in the tropics. Among them, the synthesis of glucose into fat in the human body is performed. It contains natural (-) HCA (hydroxycitric acid) to suppress (see "Development of New Food Functional Ingredients" P331 to 336). The Garcinia leaf powder is commercially available, for example, Garcinia leaf M (trade name: manufactured by Seimitsu Pharmaceutical Co., Ltd.).
【0012】前記HCAの働きにより、体内でのコレス
テロールの生成抑制が行なわれ、成人病の原因となる肥
満防止やコレステロールの低下に効果がある。そのほ
か、高いSOD消去活性を有するとともに豊富な食物繊
維が含まれており、健康維持に相乗的な働きをする。配
合割合は0.10〜1.00%であり、好ましくは0.
30〜0.70%である。The action of HCA suppresses the production of cholesterol in the body, and is effective in preventing obesity and lowering cholesterol, which cause adult diseases. In addition, it has a high SOD scavenging activity and abundant dietary fiber is included, which acts synergistically to maintain health. The blending ratio is 0.10 to 1.00%, preferably 0.
It is 30 to 0.70%.
【0013】同様にして、本発明機能強化補助食品に添
加されるブドウの種子には、ポリフェノールの一種であ
るプロアントシアニジンが含まれている(「食品と開
発」Vol.31 No.10 P8〜9、前出「新食
品機能素材の開発」P369〜374参照)。この成分
は高い抗酸化力を示すことが確認されている。ブドウの
種子粉末市販品としてはKPA−40(商品名:キッコ
ーマン株式会社製)があり、成人病や老化の重要な原因
として指摘されてきているフリーラジカルや活性酸素を
除去する作用が強い。動脈硬化予防、毛細血管抵抗性改
善、下肢静脈瘤改善、視力改善等の効能があることが報
告されている。配合量は0.05〜0.500%であ
り、0.10%の配合でその効果が発揮される。Similarly, the seeds of grape added to the function-enhancing supplement of the present invention contain proanthocyanidin, which is a kind of polyphenol ("Food and Development" Vol. 31 No. 10 P8-9). , "Development of Functional Materials for New Foods", p. 369-374). It has been confirmed that this component exhibits high antioxidant power. A commercially available product of grape seed powder is KPA-40 (trade name: manufactured by Kikkoman Corporation), which has a strong action of removing free radicals and active oxygen, which have been pointed out as important causes of adult diseases and aging. It has been reported to be effective in preventing arteriosclerosis, improving capillary resistance, improving varicose veins in the lower extremities, and improving visual acuity. The blending amount is 0.05 to 0.500%, and the effect is exhibited at a blending amount of 0.10%.
【0014】本発明において使用されるビタミンB12
は造血のビタミンと呼ばれ、赤血球、白血球の生産、リ
ン脂質合成ならびに核酸合成に働き、タンパク生合成に
関与し、神経系の正しい働きを助ける作用をするという
効果が知られている。不足することにより、免疫力低
下、動脈硬化、神経痛、関節炎、眼精疲労などの症状が
現われる。配合量は、0.01〜0.05%である。Vitamin B 12 used in the present invention
Is called a hematopoietic vitamin, and is known to have an effect of acting on the production of red blood cells and white blood cells, phospholipid synthesis and nucleic acid synthesis, participating in protein biosynthesis, and assisting the correct functioning of the nervous system. Due to lack, symptoms such as weakened immunity, arteriosclerosis, neuralgia, arthritis, and eye strain appear. The blending amount is 0.01 to 0.05%.
【0015】さらに、ビタミンEは抗酸化剤として生体
膜の不飽和脂肪酸の酸化を防ぎ細胞を守る作用をする。
黄体ホルモン、男性ホルモン、ステロイドホルモンの生
成分泌に関与し、葉酸、ビタミンB12の作用を助け、
造血に働き、赤血球の健康を保つ。血栓を防ぎ、細胞の
生命力を延ばす、生殖機能の保持等の効果がある。不足
することにより、動脈硬化、狭心症、心筋梗塞、肝臓障
害、糖尿病などの症状が現われることがある。配合量は
3.00〜8.00%であり、ビタミンB12の配合量
にあわせて調節される。Further, vitamin E acts as an antioxidant to prevent the oxidation of unsaturated fatty acids in biological membranes and protect cells.
Luteinizing hormone, male hormone, involved in the generation secretion of steroid hormones, help folic acid, the action of vitamin B 12,
It works on hematopoiesis and keeps red blood cells healthy. It has the effects of preventing blood clots, extending the vitality of cells, and maintaining reproductive function. Due to lack, symptoms such as arteriosclerosis, angina, myocardial infarction, liver damage, and diabetes may appear. The amount is 3.00 to 8.00%, is adjusted in accordance with the amount of vitamin B 12.
【0016】本発明に使用される納豆菌培養エキスには
血栓溶解作用のあるナットウキナーゼが含まれている。
市販品としては、たとえばビオチームNSK(商品名:
Japan Bio Science Laborat
ory製)がある。配合量は0.05〜1.00%がよ
く、0.10%でもその効果が十分発揮される。The natto culture extract used in the present invention contains nattokinase having a thrombolytic action.
Examples of commercially available products include Bioteam NSK (trade name:
Japan Bio Science Laborat
ory). The blending amount is preferably 0.05 to 1.00%, and even at 0.10%, the effect is sufficiently exhibited.
【0017】本発明は、前記の各原料成分を所定量ずつ
配合するとともに、これらに賦形剤として赤玉デキスト
リン、乳糖、シュガーエステルを添加し、低温、乾燥状
態下で十分に攪拌・混合し、混合物を、製薬業界で錠剤
製造に使用されている打錠機により製錠する。赤玉デキ
ストリンの配合は7〜12%である。7%未満では錠剤
強度が不十分であり、12%を超えると、服用したとき
の崩壊性が低下する。シュガーエステルは錠剤製造にお
ける滑沢剤の役割を有する。1.00〜3.00%が好
ましい範囲である。1.00%未満では効果が不十分で
あり、3.00%を超える添加は経済的でない。In the present invention, the above-mentioned respective raw material components are blended in predetermined amounts, and akadama dextrin, lactose and sugar ester are added as excipients to these, and they are sufficiently stirred and mixed at low temperature and under dry conditions, The mixture is tabletted on the tablet press used in the tablet industry in the pharmaceutical industry. The composition of Akatama dextrin is 7 to 12%. If it is less than 7%, the tablet strength is insufficient, and if it exceeds 12%, the disintegration property when taken is lowered. Sugar ester has the role of lubricant in tablet manufacture. 1.00 to 3.00% is a preferable range. If it is less than 1.00%, the effect is insufficient, and if it exceeds 3.00%, it is not economical.
【0018】以上のように配合された各成分の残部が乳
糖であり、通常、錠剤型の健康補助食品の場合に賦形の
主たる役割を有する。乳糖は哺乳動物の乳様分泌物中に
含まれており、蔗糖の約16%の甘さである。The balance of each component blended as described above is lactose, and usually has a main role of shaping in the case of tablet type health supplement. Lactose is contained in the milky secretions of mammals and is about 16% sweeter than sucrose.
【0019】形成される錠剤の寸法は、含有される緑茶
カテキンの割合によって変るが、標準的なものとしては
1錠の重さ370mg、中央錠厚4.6mm、周辺厚み
2.0mm、直径6.8mmの中膨れ形状であるが、こ
れに限定されず、その他の形状でもよく、服用を容易に
するために錠剤表面にはシェラック被覆が施されてい
る。必要に応じ糖衣コーティングなどを行なってもよ
い。The size of the tablets formed varies depending on the proportion of green tea catechin contained, but as a standard, the weight of one tablet is 370 mg, the central tablet thickness is 4.6 mm, the peripheral thickness is 2.0 mm, and the diameter is 6 The shape is a swelling shape of 0.8 mm, but the shape is not limited to this, and other shapes may be used, and the surface of the tablet is coated with shellac for easy administration. If necessary, sugar coating may be applied.
【0020】本発明機能強化補助食品の、具体的配合の
1例を示すと次の表1のとおりである。1錠の形状・寸
法は前記した標準のものとした。
The following Table 1 shows an example of a specific formulation of the function-enhancing supplement of the present invention. The shape and dimensions of one tablet were the standard ones described above.
【0021】前記配合の本発明機能強化補助食品を、通
常の職業に従事している各年齢層の男女ボランティア2
0人に服用させ、疲労回復(倦怠感の改善)の調査をし
た結果を表2〜表5に示す。2/3以上の人が示した効
果を、A:すみやかな回復、B:普通の回復、C:遅い
回復、D:効果なしの4ランクに分類した。効果の程度
を記号の数で示した。[0021] Male and female volunteers of each age group who are engaged in ordinary occupations are supplemented with the supplement of the present invention for enhancing the function of the present invention 2.
Tables 2 to 5 show the results of an investigation of fatigue recovery (improvement of fatigue) by taking 0 people. The effects exhibited by 2/3 or more persons were classified into four ranks: A: prompt recovery, B: normal recovery, C: slow recovery, D: no effect. The degree of effect was indicated by the number of symbols.
【0022】 [0022]
【0023】 [0023]
【0024】 [0024]
【0025】 [0025]
【0026】試験の結果から、高齢になるほど活性酸素
の生成が多いといわれているが、それに対しても本発明
機能強化補助食品の服用による、血液中の活性酸素の除
去が顕著に行なわれ、とくに疲労回復に有効であること
が確認された。From the results of the test, it is said that the older the generation of active oxygen is, the more active oxygen is produced in the blood by taking the function-enhancing supplement of the present invention. It was confirmed that it was particularly effective in recovering from fatigue.
【0027】[0027]
【発明の効果】本発明は以上説明したように構成されて
いるから、通常の食事からでは十分な効果が期待できな
い体内の活性酸素除去を効果的に行なってすみやかな疲
労回復が期待でき、健康増進に役立つものであって食品
産業上きわめて有用である。EFFECTS OF THE INVENTION Since the present invention is constituted as described above, it is possible to expect prompt recovery from fatigue by effectively removing active oxygen in the body, which is not expected to have a sufficient effect from a normal diet. It is useful for promotion and extremely useful in the food industry.
Claims (5)
て、少量のガルシニア葉粉末、ブドウ種子粉末、ビタミ
ンB12、ビタミンE、納豆菌培養エキスおよび賦形剤
よりなることを特徴とする機能強化補助食品。1. A functional enhancement comprising green tea catechin as a main component and a small amount of garcinia leaf powder, grape seed powder, vitamin B 12 , vitamin E, natto bacterium culture extract and an excipient as accessory components. Supplements.
ールを含む茶の葉抽出物である請求項1記載の機能強化
補助食品。2. The function-enhancing supplement according to claim 1, wherein the green tea catechin is a tea leaf extract containing at least 75% polyphenol.
%(重量%、以下同じ)、ガルシニア葉粉末:0.10
〜1.00%、ブドウ種子粉末:0.05〜0.50
%、ビタミンB12:0.01〜0.05%、ビタミン
E:3.00〜8.00%、納豆菌培養エキス:0.0
5〜1.00%、残部賦形剤である請求項1または2記
載の機能強化補助食品。3. Green tea catechin: 20.00 to 30.00
% (Weight%, the same below), Garcinia leaf powder: 0.10.
~ 1.00%, grape seed powder: 0.05-0.50
%, Vitamin B 12 : 0.01 to 0.05%, Vitamin E: 3.00 to 8.00%, Bacillus natto culture extract: 0.0
The function-enhancing supplement according to claim 1 or 2, wherein 5 to 1.00% is the balance excipient.
シュガーエステルよりなる請求項1、2または3記載の
機能強化補助食品。4. The function-enhancing supplement food according to claim 1, 2 or 3, wherein the excipient comprises red ball dextrin, lactose and sugar ester.
12.00%、シュガーエステル:1.00〜3.00
%、残部乳糖である請求項4記載の機能強化補助食品。5. The excipient is Akadama dextrin: 7.00
12.00%, sugar ester: 1.00 to 3.00
%, The balance being lactose, The function-enhancing supplement according to claim 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001245770A JP2003024010A (en) | 2001-07-10 | 2001-07-10 | Function-enhancing supplementary food comprising as main ingredient green tea catechin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001245770A JP2003024010A (en) | 2001-07-10 | 2001-07-10 | Function-enhancing supplementary food comprising as main ingredient green tea catechin |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003024010A true JP2003024010A (en) | 2003-01-28 |
Family
ID=19075453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001245770A Pending JP2003024010A (en) | 2001-07-10 | 2001-07-10 | Function-enhancing supplementary food comprising as main ingredient green tea catechin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003024010A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003088332A (en) * | 2001-09-13 | 2003-03-25 | Fancl Corp | Food for improving blood flow |
WO2005028464A1 (en) * | 2003-09-18 | 2005-03-31 | Kao Corporation | Endurance improving agent |
JP2005225804A (en) * | 2004-02-13 | 2005-08-25 | Kao Corp | Ampk activator |
WO2007083821A1 (en) * | 2006-01-19 | 2007-07-26 | Ito En, Ltd. | Anti-overstrain composition |
JP2012136547A (en) * | 2004-01-12 | 2012-07-19 | Integrated Botanical Technologies Llc | Bioactive composition from theaceous plant and process for producing and using the same |
JP2012528125A (en) * | 2009-05-29 | 2012-11-12 | ネステク ソシエテ アノニム | Green tea extract with improved bioavailability |
CN103211227A (en) * | 2013-05-07 | 2013-07-24 | 扬州大学 | Method for preparing ultramicro dietary supplement from grape seeds and wine lees materials |
JP2017042144A (en) * | 2015-08-28 | 2017-03-02 | 株式会社エレメンツ | Oral composition |
-
2001
- 2001-07-10 JP JP2001245770A patent/JP2003024010A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003088332A (en) * | 2001-09-13 | 2003-03-25 | Fancl Corp | Food for improving blood flow |
WO2005028464A1 (en) * | 2003-09-18 | 2005-03-31 | Kao Corporation | Endurance improving agent |
JP2012136547A (en) * | 2004-01-12 | 2012-07-19 | Integrated Botanical Technologies Llc | Bioactive composition from theaceous plant and process for producing and using the same |
JP2005225804A (en) * | 2004-02-13 | 2005-08-25 | Kao Corp | Ampk activator |
WO2007083821A1 (en) * | 2006-01-19 | 2007-07-26 | Ito En, Ltd. | Anti-overstrain composition |
JP2007191426A (en) * | 2006-01-19 | 2007-08-02 | Ito En Ltd | Anti-overwork composition |
JP2012528125A (en) * | 2009-05-29 | 2012-11-12 | ネステク ソシエテ アノニム | Green tea extract with improved bioavailability |
US9180077B2 (en) | 2009-05-29 | 2015-11-10 | Nestec S.A. | Green tea extracts of improved bioavailability |
CN103211227A (en) * | 2013-05-07 | 2013-07-24 | 扬州大学 | Method for preparing ultramicro dietary supplement from grape seeds and wine lees materials |
JP2017042144A (en) * | 2015-08-28 | 2017-03-02 | 株式会社エレメンツ | Oral composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE502007010071C5 (en) | USE OF A MINERAL COMPOSITION AND, WHERE APPROPRIATE, ACETOGENIC AND / OR BUTYROGENIC BACTERIA TO AVOID OR REDUCE GAS FORMATION IN THE THICKNESS OF ANIMALS AND THEREFORE COMPLAINED ABDOMINAL | |
US8968726B2 (en) | Lactoferrin and angiogenin compositions and uses thereof | |
US20090110674A1 (en) | Health supplement | |
US20080003278A1 (en) | Food products and dietary supplements for improving mental performance | |
US20220030909A1 (en) | Intact Pea Protein-Based Nutrient Composition | |
AU2009200897A1 (en) | Oils enriched with diacylglycerols and phytosterol ester for use in the reduction of cholesterol and triglycerides | |
JP6335508B2 (en) | Growth hormone secretagogue | |
KR101687982B1 (en) | Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof | |
US20090214684A1 (en) | Method for reducing body weight and improving control of body lipids | |
WO2016088996A1 (en) | Composition, using natural extracts, for treating and preventing periodontal diseases | |
JP3793764B2 (en) | Nutritional supplement containing α-glucosidase inhibitor and α-amylase inhibitor | |
KR20170099539A (en) | Sedum composition promoting antioxidant and alcohol oxidation | |
JP2003024010A (en) | Function-enhancing supplementary food comprising as main ingredient green tea catechin | |
KR20160013069A (en) | Compositions comprising a mixture of bacteria comprising pediococcus and lactobacillus and methods for decreasing the effects of alcohols | |
WO2002100393A1 (en) | Compositions for ameliorating attention-deficient/hyperactivity disorder | |
EP1186295B1 (en) | Pharmaceutical preparations containing extracts of soy isoflavone and probiotic micro-organisms | |
US20150174218A1 (en) | ANGIOGENIN COMPLEXES (ANGex) WITH ANABOLIC HORMONES FOR IMPROVING BONE HEALTH | |
KR102433586B1 (en) | Food composition for relieving hangover and improving hepatic function | |
KR102172316B1 (en) | A composition comprising rose flower extract for reducing body fat and a health functional food comprising the composition | |
JP2007008866A (en) | Hypotensive agent composition | |
EP0835119A1 (en) | Fish oil and garlic nutritive composition | |
KR102523928B1 (en) | Compositon for Improving Memory Containing Culture Extract of Bacillus Subtilis Natto | |
JP2003212775A (en) | Physiologically active composition | |
CN108095067A (en) | A kind of preparation method alleviated visual fatigue and enhance memory capsule | |
US20240307478A1 (en) | Phosphodiesterase 5 inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040413 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040817 |